Earnings Releases·Nov 3, 2026, 8:07 AM ET

Henry Schein — Third Quarter 2026 Earnings Summary

Total net sales rose 4.0% year-over-year to $3.5 billion, while GAAP diluted EPS increased 26.2% to $1.06 and non-GAAP diluted EPS rose 13.0% to $1.56.
The company raised full-year 2026 non-GAAP EPS guidance to $5.50–$5.56 (previously $5.29–$5.39) and adjusted EBITDA growth guidance to high-single-digits, while maintaining total sales growth guidance at 4.5%–5.5%.
Strong performance was driven by U.S. dental merchandise sales up 8.6% and global dental merchandise sales up 7.0%, offset by a 4.8% decline in global value-added services.
Capital return activity included $125 million in share repurchases during the quarter and $450 million year-to-date, leaving $330 million in remaining authorization.